Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06823583 · ClinicalTrials.gov registry record

Multi-Site Feasibility Testing of the Ventricular Assist Device Anticipatory Guidance Tool

A clinical trial of Ventricular Assist Device and Advanced Heart Failure, sponsored by Bryan Heart.

Recruiting
Registry status
10
Enrollment target
2
Study locations

NCT06823583: Recruiting study of Ventricular Assist Device and Advanced Heart Failure, sponsored by Bryan Heart.

NCT06823583 is a study of Ventricular Assist Device and Advanced Heart Failure that is actively recruiting participants, run by Bryan Heart. The registered enrollment target is 10 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06823583, a study of Ventricular Assist Device and Advanced Heart Failure, is actively recruiting participants, sponsored by Bryan Heart.

RECRUITING
Registry status
10 participants
Enrollment target
2
Study locations

Study Summary

There are a variety of educational documents available to help in a participant's decision for VAD implant, however there is little information available to potential participants to help understand areas of satisfaction and concern following a VAD implant as various time points. The investigators want to provide better patient care through increased education and awareness beyond surgical outcomes and contribute to patient understanding of "what to expect" following a VAD implant. The investigators have created an anticipatory guidance (AG) tool based upon previous responses recorded in a local program's database, from the Quality of Life with a Left Ventricular Assist Device (QoLVAD) questionnaire. This questionnaire has five different domains (physical, social, emotional, cognitive thinking and spiritual/well-being). Investigators have previously analyzed responses to determine common areas of satisfaction and concern at 3-, 6-, 12- and 24-months post-VAD implant to better understand quality of life when living with a VAD. Investigators have had both VAD clinicians and VAD patients initially evaluate the tool to determine accuracy and effectiveness of the anticipatory guidance (AG) tool.

Primary Outcome

Evaluate clinician perspectives of the Ventricular Assist Device Anticipatory Guidance Tool (VAD AG Tool) v5.0 for accuracy, by completing an evaluation where each item will be scored 1-4, as follows: 1 Not Relevant, 2 Somewhat Relevant, 3 Quite Relevant, 4 Highly Relevant

Study Locations (2)

Nebraska

  • Bryan Heart - Lincoln

Wisconsin

  • Advocate Aurora Health - Milwaukee

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2025-08-17
Est. Completion 2026-12
Bryan Heart

1 total trials

What NCT06823583 shows while recruiting

NCT06823583 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.

The record links to 3 conditions, with Ventricular Assist Device appearing as the primary indexed condition, and to 0 interventions.

NCT06823583 reports a single indexed study location in Nebraska, Wisconsin.

Frequently Asked Questions

What is clinical trial NCT06823583 about?

NCT06823583 is a clinical study titled "Multi-Site Feasibility Testing of the Ventricular Assist Device Anticipatory Guidance Tool". There are a variety of educational documents available to help in a participant's decision for VAD implant, however there is little information available to potential participants to help understand areas of satisfaction and concern following a VAD implant as various time points. The investigators w...

What is the current status of trial NCT06823583?

This trial is currently recruiting. The enrollment target is 10 participants. The study started on 2025-08-17. Estimated completion is 2026-12.

What conditions does trial NCT06823583 study?

This clinical trial studies the following conditions: Ventricular Assist Device, Advanced Heart Failure, Anticipatory Guidance.

Who is sponsoring clinical trial NCT06823583?

This trial is sponsored by Bryan Heart, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06823583 being conducted?

This trial has 2 study locations across Nebraska, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06823583, the US trial registry maintained by the National Library of Medicine. NCT06823583 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.